Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
CALL
Monro
MNRO
$405M
| $1.61M | ﹤0.01% |
26,400
-900
| -3% | -$54.6K |
|
3902
PUT
Euronet Worldwide
EEFT
$2.62B
| $1.61M | ﹤0.01% |
19,700
-38,600
| -66% | -$2.96M |
|
3903
Upbound Group
UPBD
$1.12B
| $1.61M | ﹤0.01% |
127,112
+28,600
| +29% | +$358K |
|
|
3904
Euronet Worldwide
EEFT
$2.62B
| $1.6M | ﹤0.01% |
19,604
-13,429
| -41% | -$1.03M |
|
|
GLOP
3905
PUT
DELISTED
GASLOG PARTNERS LP
GLOP
| $1.6M | ﹤0.01% |
+73,600
| New | +$1.47M |
|
3906
ProShares UltraShort QQQ
QID
$216M
| $1.6M | ﹤0.01% |
+825
| New | +$1.71M |
|
|
RSO
3907
CALL
DELISTED
Resource Capital Corp.
RSO
| $1.6M | ﹤0.01% |
124,900
+11,700
| +10% | +$152K |
|
3908
Quest Diagnostics
DGX
$26.8B
| $1.6M | ﹤0.01% |
18,885
-46,116
| -71% | -$3.87M |
|
|
TERP
3909
CALL
DELISTED
TerraForm Power, Inc
TERP
| $1.6M | ﹤0.01% |
114,900
-190,200
| -62% | -$2.38M |
|
3910
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$709M
| $1.6M | ﹤0.01% |
+48,539
| New | +$1.56M |
|
3911
iShares Global Healthcare ETF
IXJ
$4.31B
| $1.6M | ﹤0.01% |
+31,692
| New | +$1.63M |
|
|
SEMG
3912
CALL
DELISTED
SEMGROUP CORPORATION
SEMG
| $1.59M | ﹤0.01% |
45,100
+28,000
| +164% | +$890K |
|
|
SYT
3913
CALL
DELISTED
Syngenta Ag
SYT
| $1.59M | ﹤0.01% |
18,200
-88,100
| -83% | -$7.26M |
|
|
IM
3914
CALL
DELISTED
Ingram Micro
IM
| $1.59M | ﹤0.01% |
44,700
-94,000
| -68% | -$3.26M |
|
3915
PUT
Western Midstream Partners
WES
$20B
| $1.59M | ﹤0.01% |
37,500
+5,000
| +15% | +$188K |
|
|
JPXN
3916
iShares JPX-Nikkei 400 ETF
JPXN
$139M
| $1.59M | ﹤0.01% |
29,292
-2,700
| -8% | -$142K |
|
|
FDC
3917
DELISTED
First Data Corporation
FDC
| $1.59M | ﹤0.01% |
120,841
+105,241
| +675% | +$1.36M |
|
3918
PUT
LPL Financial
LPLA
$29.2B
| $1.59M | ﹤0.01% |
53,100
-68,600
| -56% | -$1.86M |
|
|
AMWD
3919
CALL
DELISTED
American Woodmark
AMWD
| $1.59M | ﹤0.01% |
19,700
-2,100
| -10% | -$164K |
|
3920
Barings BDC
BBDC
$979M
| $1.59M | ﹤0.01% |
80,531
+33,331
| +71% | +$658K |
|
3921
CALL
Allegion
ALLE
$13.4B
| $1.58M | ﹤0.01% |
23,000
+17,700
| +334% | +$1.25M |
|
3922
Vanguard Morningstar Mega Cap ETF
MGC
$10.3B
| $1.58M | ﹤0.01% |
+21,483
| New | +$1.58M |
|
3923
NiSource
NI
$19.5B
| $1.58M | ﹤0.01% |
65,700
| – | – |
|
3924
CALL
Brookfield Infrastructure Partners
BIP
$17.5B
| $1.58M | ﹤0.01% |
76,776
-77,448
| -50% | -$1.49M |
|
3925
CALL
Boise Cascade
BCC
$2.75B
| $1.58M | ﹤0.01% |
62,300
+3,100
| +5% | +$79.6K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.